StockData
NMRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Neumora Therapeutics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.47−0.00 (-0.80%)

Close on Oct 19, 2026

Market cap
$87.03M
P/E (TTM)
–
Dividend yield
–

SEC filings

40 of Neumora Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QJun 30, 2026Aug 14, 2026SEC EDGAR
Current report8-KAug 14, 2026Aug 14, 2026SEC EDGAR
Current report8-KJul 27, 2026Jul 27, 2026SEC EDGAR
Current report8-KJun 10, 2026Jun 15, 2026SEC EDGAR
Current report8-KMay 27, 2026May 29, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 7, 2026SEC EDGAR
Current report8-KMay 7, 2026May 7, 2026SEC EDGAR
Proxy statementDEF 14AMay 27, 2026Apr 17, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 30, 2026SEC EDGAR
Current report8-KMar 30, 2026Mar 30, 2026SEC EDGAR
Current report8-KFeb 11, 2026Feb 11, 2026SEC EDGAR
Current report8-KJan 12, 2026Jan 12, 2026SEC EDGAR
Current report8-KJan 5, 2026Jan 5, 2026SEC EDGAR
Current report8-KNov 17, 2025Nov 21, 2025SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 6, 2025SEC EDGAR
Current report8-KNov 6, 2025Nov 6, 2025SEC EDGAR
Current report8-KOct 27, 2025Oct 27, 2025SEC EDGAR
Current report8-KOct 27, 2025Oct 27, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 6, 2025SEC EDGAR
Current report8-KAug 6, 2025Aug 6, 2025SEC EDGAR
Current report8-KMay 28, 2025May 30, 2025SEC EDGAR
Current report8-KMay 14, 2025May 16, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 12, 2025SEC EDGAR
Current report8-KMay 12, 2025May 12, 2025SEC EDGAR
Proxy statementDEF 14AMay 28, 2025Apr 29, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 3, 2025SEC EDGAR
Current report8-KMar 3, 2025Mar 3, 2025SEC EDGAR
Current report8-KFeb 13, 2025Feb 13, 2025SEC EDGAR
Current report8-KJan 13, 2025Jan 13, 2025SEC EDGAR
Current report8-KJan 2, 2025Jan 2, 2025SEC EDGAR
Quarterly report10-QSep 30, 2024Nov 12, 2024SEC EDGAR
Current report8-KNov 12, 2024Nov 12, 2024SEC EDGAR
Quarterly report10-QJun 30, 2024Aug 6, 2024SEC EDGAR
Current report8-KAug 6, 2024Aug 6, 2024SEC EDGAR
Current report8-KJun 13, 2024Jun 14, 2024SEC EDGAR
Quarterly report10-QMar 31, 2024May 7, 2024SEC EDGAR
Current report8-KMay 7, 2024May 7, 2024SEC EDGAR
Proxy statementDEF 14AJun 13, 2024Apr 25, 2024SEC EDGAR
Current report8-KApr 15, 2024Apr 15, 2024SEC EDGAR
Current report8-KMar 7, 2024Mar 7, 2024SEC EDGAR